NCT02737579 is a NA clinical trial of XFM guidance in Congenital Heart Defect, sponsored by Joshua Kanter.

Who is sponsoring NCT02737579?

NCT02737579 is sponsored by Joshua Kanter.

What drugs are being tested in NCT02737579?

Interventions in NCT02737579: XFM guidance.

What condition does NCT02737579 study?

NCT02737579 studies Congenital Heart Defect.

Is NCT02737579 still recruiting?

NCT02737579 is currently completed. Last updated 6 February 2024.

Last reviewed 2024-02-06 · How we verify

NCT02737579

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

XFM: (X-ray Fused With MRI) Guided Cardiac Catheterization

Completed NA Last updated 6 February 2024

What this trial tests

NA trial testing XFM guidance in Congenital Heart Defect in 27 participants. Completed in 27 May 2022.

Timeline

23 July 2013

Primary endpoint
27 May 2022

27 May 2022

Quick facts

Lead sponsor	Joshua Kanter
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	27
Start date	23 July 2013
Primary completion	27 May 2022
Estimated completion	27 May 2022
Sites	1 location across United States

Drugs / interventions tested

XFM guidance

Conditions studied

Congenital Heart Defect — all drugs for Congenital Heart Defect →

Sponsor

Joshua Kanter

Who can join

Eligibility, any sex, with Congenital Heart Defect. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will evaluate the use of x-ray fused with MR images as an imaging tool to help guide catheter tools during diagnostic and therapeutic cardiac catheterization procedures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Congenital Heart Defect

Currently open trials in the same condition.

NCT05698277 — Automated Fetal Cardiac Function in Babies Affected by Heart Diseases · recruiting
NCT04271358 — Peer Coaching Intervention in Young Adults With Congenital Heart Disease · NA · active not recruiting
NCT04437069 — Improving Patient and Family Health Using Family-Centered Outcomes and Shared Decision-Making · NA · active not recruiting
NCT04106479 — NIRS in Congenital Heart Defects - Correlation With Echocardiography · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02737579 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Joshua Kanter
Last refreshed: 6 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02737579.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing